NEVVI Medicare utilization intelligence
or

← back

Provider profile

AURORA, VIKAS MD

Hematology-Oncology · NPI 1033309240 · GRAPEVINE, TX

1
Groups
56
Codes · 2024
38,501
Disclosed services

AURORA, VIKAS is a Hematology-Oncology in GRAPEVINE, TX, a member of 1 medical group, who billed 56 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

38,501
disclosed services
56
codes billed to Medicare Part B
Prior year · CY2023 33,981 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1756 Injection, iron sucrose, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J1100 Injection, dexamethasone sodium phosphate, 1 mg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
83615 Lactate dehydrogenase (enzyme) level
J1626 Injection, granisetron hydrochloride, 100 mcg
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J2469 Injection, palonosetron hcl, 25 mcg
82378 Carcinoembryonic antigen (cea) protein level
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
83521 Measurement of immunoglobulin light chains
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96413 Administration of chemotherapy into vein, 1 hour or less
J9190 Injection, fluorouracil, 500 mg
85055 Reticulated (young) platelet measurement
82746 Folic acid level, serum
82607 Cyanocobalamin (vitamin b-12) level
J3489 Injection, zoledronic acid, 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
96372 Injection of drug or substance under skin or into muscle
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
84443 Blood test, thyroid stimulating hormone (tsh)
96523 Irrigation of implanted venous access drug delivery device
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96415 Administration of chemotherapy into vein, each additional hour
J7030 Infusion, normal saline solution , 1000 cc
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
83010 Haptoglobin (serum protein) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83735 Magnesium level
96360 Infusion into a vein for hydration, 31-60 minutes
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
78816 Nuclear medicine study whole body with ct scan
82232 Beta-2 microglobulin (protein) level
J3490 Unclassified drugs
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
71250 Ct scan of chest without contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.